Correction: Maximum efficacy of mesenchymal stem cells in rat model of renal ischemia-reperfusion injury: Renal artery administration with optimal numbers (PLoS ONE (2014) 9, 3 (e92347) DOI: 10.1371/journal.pone.0092347);Maximum efficacy of mesenchymal stem cells in rat model of renal ischemia-reperfusion injury: Renal artery administration with optimal numbers

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Cai, Jieru ^a   Yu, Xiaofang ^a   Xu, Rende ^b   Fang, Yi ^a   Qian, Xiaoqin ^a   Liu, Shaopeng ^a   Teng, Jie ^a   Ding, Xiaoqiang ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CELL COUNT; CONTROLLED STUDY; ECHOGRAPHY; ENGRAFTMENT; FLUORESCENCE MICROSCOPY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; RAT; RENAL ARTERY; REPERFUSION INJURY; VEIN;

ANIMALS; DISEASE MODELS, ANIMAL; INJECTIONS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PUNCTURES; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; RENAL ARTERY; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 84898640461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101336     Document Type: Erratum

References (29)

1. Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N Engl J Med 334: 1448-1460. (Pubitemid 126590563)
2. Devarajan P (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17: 1503-1520. (Pubitemid 43841396)
3. Fang Y, Ding X, Zhong Y, Zou J, Teng J, et al. (2010) Acute kidney injury in a Chinese hospitalized population. Blood Purif 30: 120-126.
4. Fiorina P, Ansari MJ, Jurewicz M, Barry M, Ricchiuti V, et al. (2006) Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol 17: 716-723.
5. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nat Med 17: 1391-1401.
6. Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, et al. (2013) Acute kidney injury: an increasing global concern. Lancet 382: 170-179.
7. Togel F, Hu ZM, Weiss K, Isaac J, Lange C, et al. (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. American Journal of Physiology-Renal Physiology 289: F31-F42. (Pubitemid 40863570)
8. Jurewicz M, Yang S, Augello A, Godwin JG, Moore RF, et al. (2010) Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes 59: 3139-3147.
9. Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, et al. (2009) Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183: 993-1004.
10. Francese R, Fiorina P (2010) Immunological and regenerative properties of cord blood stem cells. Clin Immunol 136: 309-322.
11. Fiorina P, Voltarelli J, Zavazava N (2011) Immunological applications of stem cells in type 1 diabetes. Endocr Rev 32: 725-754.
12. Togel F, Yang Y, Zhang P, Hu ZM, Westenfelder C (2008) Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. American Journal of Physiology-Renal Physiology 295: F315-F321.
13. Zhang L, Li K, Liu X, Li D, Luo C, et al. (2013) Repeated Systemic Administration of Human Adipose-Derived Stem Cells Attenuates Overt Diabetic Nephropathy in Rats. Stem Cells Dev.
14. Li SH, Lai TY, Sun Z, Han M, Moriyama E, et al. (2009) Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intraaortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg 137: 1225-1233 e1221.
15. Mias C, Trouche E, Seguelas MH, Calcagno F, Dignat-George F, et al. (2008) Ex vivo pretreatment with melatonin improves survival, proangiogenic/ mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 26: 1749-1757.
16. Yu X, Lu C, Liu H, Rao S, Cai J, et al. (2013) Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. Plos One 8: e62703.
17. Allam R, Scherbaum CR, Darisipudi MN, Mulay SR, Hagele H, et al. (2012) Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 23: 1375-1388.
18. Turetschek K, Nasel C, Wunderbaldinger P, Diem K, Hittmair K, et al. (1996) Power Doppler versus color Doppler imaging in renal allograft evaluation. J Ultrasound Med 15: 517-522. (Pubitemid 26256408)
19. Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, et al. (2005) Administered mesenchymal stem cells enhance recovery from ischemia/ reperfusion-induced acute renal failure in rats. Kidney International 68: 1613-1617. (Pubitemid 43169906)
20. Hagiwara M, Shen B, Chao L, Chao JLM (2008) Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Human Gene Therapy 19: 807-819.
21. Burst VR, Gillis M, Putsch F, Herzog R, Fischer JH, et al. (2010) Poor Cell Survival Limits the Beneficial Impact of Mesenchymal Stem Cell Transplantation on Acute Kidney Injury. Nephron Experimental Nephrology 114: E107-E116.
22. Campbell NG, Suzuki K (2012) Cell Delivery Routes for Stem Cell Therapy to the Heart: Current and Future Approaches. Journal of Cardiovascular Translational Research 5: 713-726.
23. Alfarano C, Roubeix C, Chaaya R, Ceccaldi C, Calise D, et al. (2012) Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. Cell Transplant 21: 2009-2019.
24. Monteiro Carvalho Mori da Cunha MG, Beckmann DV, Carlon MS, Zia S, Pippi NL, et al. (2013) A surgical technique for homogenous renal distribution of substances in rats. Eur Surg Res 51: 58-65.
25. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, et al. (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18: 683-692.
26. Shih YC, Lee PY, Cheng H, Tsai CH, Ma H, et al. (2013) Adipose-derived stem cells exhibit antioxidative and antiapoptotic properties to rescue ischemic acute kidney injury in rats. Plast Reconstr Surg 132: 940e-951e.
27. Zhuo W, Liao L, Fu Y, Xu T, Wu W, et al. (2013) Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemiareperfusion- induced renal dysfunction in rats. Transplant Proc 45: 503-510.
28. Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, et al. (2006) Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 17: 2202-2212. (Pubitemid 44141910)
29. De Martino M, Zonta S, Rampino T, Gregorini M, Frassoni F, et al. (2010) Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation. Transplant Proc 42: 1331-1335.